Pathogenic effects of central nervous system hyperarousal

Medical Hypotheses

Volumn 71, Issue 2, 2008, Pages 212-217

  Duke, Bill J ^a  

^a Child Psychopharmacology Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROUSAL; ARTICLE; BRAIN PROTECTION; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DISEASE SEVERITY; HUMAN; IRRITABILITY; MENTAL DISEASE; MENTAL INSTABILITY; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROPSYCHIATRY; PRIORITY JOURNAL; TREATMENT RESPONSE;

AFFECT; AGING; ANTIDEPRESSIVE AGENTS; AROUSAL; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; MULTIPLE SCLEROSIS; NEURONAL PLASTICITY; SLEEP; TREATMENT OUTCOME;

EID: 45649085408     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.03.037     Document Type: Article

References (31)

1. Espiritu J.R. Aging-related sleep changes. Clin Geriatr Med 24 1 (2008) 1-14
2. Herman J.P. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system. Cell Mol Neurobiol 13 4 (1993) 349-372
3. Herman J. Glucocorticoid receptor mechanisms stress and aging. from NLM Gateway: (Retrieved 06. 03. 2008).
4. Banasr M., and Duman R.S. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets 6 5 (2007) 311-320
5. Purves D. Neuroscience, 2nd ed. Sunderland, MA 01375, USA: Sinauer Associates Inc.; 2001.
6. Bengtsson S.L., Nagy Z., Skare S., Forsman L., Forssberg H., and Ullén F. Extensive piano practicing has regionally specific effects on white matter. Nat Neurosci. 8 9 (2005) 1148-1150
7. Fields R.D. White matter matters. Sci Am (2008) 54-61
8. Rich B.A., Schmajuk M., Perez-Edgar K.E., Fox N.A., Pine D.S., and Leibenluft E. Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation. Am J Psychiatr 164 2 (2007) 309-317
9. Menning H, Renz A, Seifert J, Maercker A. Reduced mismatch negativity in posttraumatic stress disorder: A compensatory mechanism for chronic hyperarousal? Int J Psychophysiol. 2008;(Jan 10).
10. Patacchioli F.R., Monnazzi P., Scontrini A., Tremante E., Caridi I., and Brunetti E. Adrenal dysregulation in amyotrophic lateral sclerosis. J Endocrinol Invest. 26 12 (2003) RC23-RC25
11. Calhoun P.S., Wiley M., Dennis M.F., Means M.K., Edinger J.D., and Beckham J.C. Objective evidence of sleep disturbance in women with posttraumatic stress. J Trauma Stress. 20 6 (2007) 1009-1018
12. Turek F.W., Penev P., Zhang Y., van Reeth O., and Zee P. Effects of age on the circadian system. Neurosci Biobehav Rev 19 1 (1995) 53-58
13. Hauer J.M., Wical B.S., and Charnas L. Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics 119 2 (2007) e519-e522
14. Carey T.J., Moul D.E., Pilkonis P., Germain A., and Buysse D.J. Focusing on the experience of insomnia. Behav Sleep Med 3 2 (2005) 73-86
15. Farchione T.R., Birmaher B., Axelson D., Kalas C., Monk K., Ehmann M., et al. Aggression, hostility, and irritability in children at risk for bipolar disorder. Bipolar Disord 9 5 (2007) 496-503
16. Monnelly E.P., Ciraulo D.A., Knapp C., and Keane T. Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol 23 2 (2003) 193-196
17. Colombo M., Vitali S., Cairati M., Vaccaro R., Andreoni G., and Guaita A. Behavioral and psychotic symptoms of dementia (BPSD) improvements in a special care unit: a factor analysis. Arch Gerontol Geriatr. 44 Suppl. 1 (2007) 113-120
18. Greenwood C.E., Tam C., Chan M., Young K.W., Binns M.A., and van Reekum R. Behavioral disturbances, not cognitive deterioration, are associated with altered food selection in seniors with Alzheimer's disease. J Gerontol A Biol Sci Med Sci 60 4 (2005) 499-505
19. Sovner R., and Fogelman S. Irritability and Mental Retardation. Semin Clin Neuropsychiatry 1 2 (1996) 105-114
20. Salvatore P., Ghidinic S., Zita G., De Panfilis C., Lambertinoc S., Maggini C., et al. Circadian activity rhythm abnormalities in ill. Bipolar Disorders 10 (2008) 256-265
21. Jones S.H., Hare D.J., and Evershed K. Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder. Bipolar Disord 7 2 (2005) 176-186
22. Staton D. The impairment of pediatric bipolar sleep: Hypotheses regarding a core defect and phenotype-specific sleep disturbances. J Affect Disord Nov 12 (2007)
23. Carlson P.J., Singh J.B., Zarate C.A., Drevets W.C., and Manji H.K. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 3 1 (2006) 22-41
24. Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J and the EMBLEM Advisory Board. Rapid-cycling bipolar I disorder: Course and treatment outcome of a large sample. J Psychiatr Res 2008;(Feb 7) [Epub ahead of print].
25. Basta M., Chrousos G., Vela-Brueno A., and Vgontzas A. Chronic insomnia and stress system. Sleep Med Clin 2 2 (2007) 279-291
26. Ghaffar O, Chamelian L, Feinstein A. Neuroanatomy of pseudobulbar affect : A quantitative MRI study in multiple sclerosis. J Neurol. 2008;(Feb 26).
27. Derache N., Marié R.M., Constans J.M., and Defer G.L. Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load. J Neurol Sci 245 1-2 (2006) 103-109
28. Gleason M.M., Egger H.L., Emslie G.J., Greenhill L.L., Kowatch R.A., Lieberman A.F., et al. Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatr 46 12 (2007) 1532-1572
29. Delate TG. Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatr Serv 2004;55(April):387-91.
30. Olfson M., Blanco C., Liu L., Moreno C., and Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 63 6 (2006) 679-685
31. Miller A., and Panitch H. Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect. J Neurol Sci. 259 1-2 (2007) 67-73